NVST Quote, Financials, Valuation and Earnings

Biolase has a net margin of 0.18% compared to Envista Holdings's net margin of -13.16%. Envista Holdings's return on equity of -32.33% beat Biolase's return on equity of -21668.17%.

Envista Holdings has a consensus price target of $20.75, signalling upside risk potential of 26.22%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 19900%. Given that Biolase has higher upside potential than Envista Holdings, analysts believe Biolase is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.120, which suggesting that the stock is 12.044% more volatile than S&P 500. In comparison Biolase has a beta of 0.211, suggesting its less volatile than the S&P 500 by 78.874%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are larger than Biolase quarterly revenues of $10.9M. Envista Holdings's net income of $1.2M is higher than Biolase's net income of -$1.4M. Notably, Envista Holdings's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.13x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

Milestone Scientific has a net margin of 0.18% compared to Envista Holdings's net margin of -58.13%. Envista Holdings's return on equity of -32.33% beat Milestone Scientific's return on equity of -61.33%.

Envista Holdings has a consensus price target of $20.75, signalling upside risk potential of 26.22%. On the other hand Milestone Scientific has an analysts' consensus of -- which suggests that it could grow by 123.12%. Given that Milestone Scientific has higher upside potential than Envista Holdings, analysts believe Milestone Scientific is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.120, which suggesting that the stock is 12.044% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.429%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are larger than Milestone Scientific quarterly revenues of $2.5M. Envista Holdings's net income of $1.2M is higher than Milestone Scientific's net income of -$1.5M. Notably, Envista Holdings's price-to-earnings ratio is -- while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.13x versus 8.41x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Solventum has a net margin of 0.18% compared to Envista Holdings's net margin of 1.49%. Envista Holdings's return on equity of -32.33% beat Solventum's return on equity of 9.76%.

Envista Holdings has a consensus price target of $20.75, signalling upside risk potential of 26.22%. On the other hand Solventum has an analysts' consensus of $80.89 which suggests that it could grow by 17.95%. Given that Envista Holdings has higher upside potential than Solventum, analysts believe Envista Holdings is more attractive than Solventum.

Envista Holdings has a beta of 1.120, which suggesting that the stock is 12.044% more volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings pays -- of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are smaller than Solventum quarterly revenues of $2.1B. Envista Holdings's net income of $1.2M is lower than Solventum's net income of $31M. Notably, Envista Holdings's price-to-earnings ratio is -- while Solventum's PE ratio is 24.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.13x versus 1.44x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona has a net margin of 0.18% compared to Envista Holdings's net margin of -47.51%. Envista Holdings's return on equity of -32.33% beat Dentsply Sirona's return on equity of -32.39%.

Envista Holdings has a consensus price target of $20.75, signalling upside risk potential of 26.22%. On the other hand Dentsply Sirona has an analysts' consensus of $19.50 which suggests that it could grow by 42.86%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

Envista Holdings has a beta of 1.120, which suggesting that the stock is 12.044% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.918, suggesting its less volatile than the S&P 500 by 8.232%.

Envista Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.69% to investors and pays a quarterly dividend of $0.16 per share. Envista Holdings pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

Envista Holdings quarterly revenues are $652.9M, which are smaller than Dentsply Sirona quarterly revenues of $905M. Envista Holdings's net income of $1.2M is higher than Dentsply Sirona's net income of -$430M. Notably, Envista Holdings's price-to-earnings ratio is -- while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings is 1.13x versus 0.73x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.